Brisou G, Paillassa J, Bernard S, Tournilhac O, et al. Clinical benefit of tafasitamab plus lenalidomide in relapsed or refractory diffuse large Bcell lymphoma: real-world data from the EarlyMIND study. Haematologica 2025 May 15. doi: 10.3324/haematol.2024.287141.
PMID: 40371897